<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1875747</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>1991 May 18 </dc:date>
<dc:title xml:lang="es">Expertos internacionales comentaron las caracter√≠sticas de perindopril, un nuevo inhibidor de la ECA de gran potencia y bien tolerado. Perindopril ha podido reducir el grosor y la rigidez de la pared arterial en estudios con animales.</dc:title>
<dc:title xml:lang="en">[International experts commented on the characteristics of perindopril, a new highly potent and well tolerated ACE. Perindopril has been able to reduce the thickness and rigidity of the arterial wall in animal studies].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
